InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: None

Friday, 03/26/2021 4:01:22 PM

Friday, March 26, 2021 4:01:22 PM

Post# of 425636
Budapest, Hungary, March, 26, 2021 (Ihub) – HDGabor today announced that the Europen Commision granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for "Vazkepa - icosapent ethyl", - marketed by Amarin Corporation plc (NASDAQ:AMRN) - a medicinal product for human use.

European Commission - C(2021)2304 - Register of Commission documents (europa.eu)

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Notice: This post is not investment advice, and not a recommendation to neither buy nor hold nor sell.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News